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Abstract
We conduct an imaging genetics study to explore how effective brain connectivity
in the default mode network (DMN) may be related to genetics within the context
of Alzheimer’s disease and mild cognitive impairment. We develop an analysis of
longitudinal resting-state functional magnetic resonance imaging (rs-fMRI) and genetic
data obtained from a sample of 111 subjects with a total of 319 rs-fMRI scans from
the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. A Dynamic Causal
Model (DCM) is fit to the rs-fMRI scans to estimate effective brain connectivity within
the DMN and related to a set of single nucleotide polymorphisms (SNPs) contained in
an empirical disease-constrained set.
We examine longitudinal data in both a 4-region and an 8-region network and
relate longitudinal effective brain connectivity networks estimated using spectral DCM
to SNPs using both linear mixed effect (LME) models as well as function-on-scalar
regression (FSR). In both networks we find evidence of potential association between
the connectivity of several DMN regions and SNPs lying in the disease-constrained set.
1 Introduction
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by cognitive decline
and progressive dementia and is thought to be caused by aberrant connections between
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cerebral regions involved in cognitive functioning (Li et al., 2013). Imaging genetics is an
important area of scientific investigation in the search for genetic biomarkers of neurodegen-
erative disease, and in increasing our understanding of the genetic basis of brain structure
and function in health and disease.
The development of analytical methods for the joint analysis of neuroimaging phenotypes
and genetic data is an important area of statistical research with many challenges. Recent
reviews are provided in Liu and Calhoun (2014) and Nathoo et al. (2019). A great deal of
work in imaging genetics has focussed on methods and analysis for examining the relationship
between brain structure and genetics (see e.g., Stein et al., 2010; Hibar et al., 2011; Ge
et al., 2012; Zhu et al., 2014; Greenlaw et al., 2017; Szefer et al., 2017; Lu et al., 2017;
Song et al., 2019). Thompson et al. (2013) give an extensive overview of methods for the
analysis of genetic data and brain connectivity with a broad focus on both diffusion tensor
imaging (DTI) and fMRI data. These authors discuss the heritability of both structural
and functional brain connectivity. Methods for the analysis of brain connectivity with an
emphasis on structural connectomes is discussed in Zhang et al. (2018, 2019).
Our focus in this article is in exploring potential associations between brain connectiv-
ity and genetics within the context of Alzheimer’s disease and mild cognitive impairment.
Effective brain connectivity and causal inference is discussed in Lindquist and Sobel (2016),
and functional connectivity analysis for fMRI data is reviewed in Cribben and Fiecas (2016).
Patel et al. (2006) and Chen et al. (2016) develop Bayesian approaches for modelling brain
connectivity and Bowman et al. (2012) consider the analysis of fMRI functional connectiv-
ity using a multimodal approach. Here, effective connectivity refers to a directed measure
of dependence from one brain region to another (see, e.g., Friston, 1994), while functional
connectivity refers to the correlation between measured time series over different locations.
In this paper we conduct an analysis examining the relationship between genetics and
effective brain connectivity as measured by rs-fMRI within the default mode network (DMN).
The DMN consists of a set of brain regions that tend to be active in resting-state, when a
subject is mind wandering with no intended task. In this state DMN regions will exhibit
low frequency signals that tend to couple together. We consider networks comprised of four
(DMN4 - 16 connections) and subsequently eight (DMN8 - 64 connections) core regions of
the DMN. The DMN4 analyses are based on network nodes located at the medial prefrontal
cortex (MPFC), the posterior cingulate cortex (PCC), the left and right intraparietal cortex
(LIPC and RIPC) with the Montreal Neurological Institute (MNI) locations for these regions
depicted in Figure 1. The DMN8 analyses are based on eight regions whose MNI locations
are specified in Table 1. The regions we consider in DMN4 are a subset of the regions
considered in DMN8 which, in addition to the original four regions, have added the left
inferior temporal region (LIT), right inferior temporal region (RIT), the left hippocampus
(LH) and the right hippocampus (RH).
Our analyses involve examining effective connectivity networks from rs-fMRI data using
Dynamic Causal Modeling (DCM; Li et al., 2011; Friston et al., 2003; Friston et al., 2014;
Razi et al., 2015; Friston et al., 2017), a nonlinear state-space framework for inferring inter-
action between latent neuronal states. We apply DCM to rs-fMRI using the SPM12 (version
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- v71219) software (Penny et al., 2011). Resting-state fMRI data are examined with the goal
of investigating the potential interaction between different areas of the brain and to explore
the potential association between this neuronal interaction in four (DMN4) and then eight
(DMN8) core regions of the DMN and SNPs that are contained in a disease-constrained set.
The DCM framework leads to directed networks and these networks are related to genetic
data using longitudinal rs-fMRI analysis. Previous literature focussing on AD has found
alterations to both effective and functional resting-state connectivity in the DMN (see e.g.,
Wu et al., 2011; Yang et al., 2013; Luo et al., 2018). Zhong et al. (2014) conduct an rs-fMRI
study and demonstrate changes in directed functional connectivity in the DMN for subjects
with AD, while Dipasquale et al. (2015) apply high-dimensional independent component
analysis (ICA) to an rs-fMRI study and demonstrate changes in functional connectivity in
subjects with AD.
Our specific choice of regions which represent the nodes of the network is motivated by
existing literature examining connectivity in the DMN and establishing the heritability of
effective connectivity for networks based on these regions. These regions are a subset of
the DMN regions considered in the rs-fMRI study of Wu et al., (2011), which demonstrated
altered DMN functional and effective connectivity in AD, and for DMN4 they are the same
regions considered in the rs-fMRI study of Sharaev et al. (2016), which investigated internal
DMN relationships. Xu et al. (2017) examine effective connectivity in these four regions of
the DMN using DCM and structural equation modelling in a twin study based on a sample
of n = 46 pairs of twins with rs-fMRI. These authors find evidence for the heritability
of effective connectivity in this network. They estimate the heritability of DMN effective
connectivity in these regions to be 0.54. Their study provides evidence that there are genes
involved in DMN effective connectivity for the network nodes depicted in Figure 1. This
work paves the way for our study of relationships between effective connectivity and genetic
markers in the same network.
Glahn et al. (2010) use an extended pedigree design and rs-fMRI to examine genetic
influence on functional connectivity within the DMN. Their study estimates the heritability
of DMN functional connectivity to be 0.424 ± 0.17. Importantly, Glahn et al. (2010)
also suggest that the genetic factors that influence DMN functional connectivity and the
genetic factors that influence gray matter density in these regions seem to be distinct. This
result then motivates the search for genetic markers associated with DMN connectivity.
Stingo et al. (2013) focus on relating brain connectivity to genetics and develop a Bayesian
hierarchical mixture model for studies involving fMRI data. The mixture components of the
proposed model correspond to the classification of the study subjects into subgroups, and
the allocation of subjects to these mixture components is linked to genetic covariates with
regression parameters assigned spike-and-slab priors.
Our strategy for data analysis proceeds as follows. We view both disease and rs-fMRI
as measures of the brain and our fundamental interest is to relate these measures of the
brain to genetics. The former is a coarse measure with three categories while the latter is a
far a more detailed measure allowing for the investigation of statistical dependencies in the
temporal rs-fMRI signal at different regions.
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We use a genome-wide scan of disease to select a priority subset of SNPs and this serves
as a constraint on the SNPs that we relate to effective brain connectivity in subsequent
analysis. We relate effective brain connectivity as characterized through spectral DCM to
the empirical disease-constrained subset of genetic variables using longitudinal analyses based
on both linear mixed effect (LME) models and function-on-scalar (FSR) regression (Yao et
al., 2005).
The remainder of the paper proceeds as follows. In Section 2 we discuss the neuroimaging
and genetic data preprocessing, present basic summaries and the use of spectral DCM for
characterizing effective connectivity. The underlying state-space model and its estimation is
discussed briefly. In Section 3 we examine how the genetic data are related to disease using a
GWAS with 1,220,955 SNPs. In doing so, we obtain an empirical disease-constrained set of
SNPs for subsequent analysis examining the association between effective brain connectivity
and genetics. In Section 4.1 we relate effective connectivity in DMN4 obtained from longi-
tudinal rs-fMRI to genetics using LME and FSR respectively. In Section 4.2 we apply this
same analysis to DMN8. The paper concludes in Section 5 with a summary of our primary
findings, a discussion of our analysis and its limitations, follow-up analyses and possible new
methodological development that is motivated by the current work.
2 Data and Preprocessing
Data used in the preparation of this article were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was launched in
2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD.
The primary goal of ADNI has been to test whether serial magnetic resonance imaging
(MRI), positron emission tomography (PET), other biological markers, and clinical and
neuropsychological assessment can be combined to measure the progression of MCI and early
AD. For up-to-date information, see www.adni-info.org. ADNI is an ongoing, longitudinal,
multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers
for the early detection and tracking of AD.
The selection criteria for our sample is as follows. We first begin with ADNI2 subjects
(1437 at this stage) and consider those subjects with genome-wide data (774 left at this
stage) and also with at least one resting-state fMRI scan at 3T (111). This leads to 111
subjects comprising 36 cognitively normal (CN), 63 MCI and 12 AD subjects, with these
subjects having a mean age of 73.8 years with the range being 56.3-95.6 years, 46 of these
subjects being male, 5 being left-handed, and with education measured in years ranging from
11 to 20.
Table 2 presents several summary statistics associated with our sample, including a sum-
mary on the APOE gene. The APOE gene is a known genetic determinant of AD risk and
individuals carrying the 4 allele are at an increased risk of AD (see, e.g., Liu et al. 2013).
Table 2 summarizes the number of APOE 4 alleles for the subjects in each disease category.
In line with expectations from the literature (Genin et al., 2011), a signal from the APOE
gene is present in the data (p-value = 0.0045; Fisher’s Exact Test) with the AD group having
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a higher percentage of subjects with at least one 4 allele. In fact, the data summaries in
Table 2 indicate that all but one of the AD subjects have at least one 4 allele of the APOE
gene.
Diagnostic classification of AD participants was made by ADNI investigators according
to diagnostic criteria for probable AD established by the National Institute of Neurological
and Communicative Disorders and Stroke and the Alzheimer’s Disease Related Disorders
Association (NINCDS-ADRA; McKhann et al., 1984). Participants in the AD cohort also
exhibited abnormal memory function on the Logical Memory II subscale of the revised
Wechsler Memory Scale (WMS II, ≤ 8 for 16 years education and above), a Mini Mental
State Exam (MMSE) between 20 and 26 (inclusive), and a Clinical Dementia Rating of
0.5 (very mild) or 1 (mild). All control participants were free of memory complaints and
deemed cognitively normal based on clinical assessments by the site physician showing an
absence of significant impairment in cognitive functioning and performance of daily activities.
Participants in the control cohort also exhibited normal memory function on the Logical
Memory II subscale of the revised WMS (WMS II, ≤ 9 for 16 years of education and above),
a MMSE score between 24 and 30 (inclusive), and a Clinical Dementia Rating of 0. For
more information on group classifications, including all additional eligibility criteria, please
consult the ADNI2 procedures manual (ADNI, 2008).
Our analysis examines longitudinal rs-fMRI data from 111 subjects with repeated mea-
surements resulting in a total of 424 rs-fMRI scans to begin with. Each scan leads to a
network which has an associated follow-up time. As the longitudinal data in this study are
quite sparse, we apply the Principal Analysis by Conditional Expectation (PACE; Muller,
2008) method which focuses on recovering the entire continuous-time temporal trajectory
of the network edge parameters. As a result of the sparsity of the longitudinal data, it is
necessary to borrow information across subjects to recover the temporal trend of the net-
work edge parameters for individual subjects. Doing so requires us to restrict the temporal
trajectory within a time window (of length 500 days) covering all subjects. The proportion
of subjects with scans outside of the 500 day window is not sufficient to recover the temporal
trajectory outside of the window, and thus we restrict our analysis to the 319 rs-fMRI scans
falling within it. The advantage of doing this is that we are able to use the function-on-scalar
regression model where the response is the temporal profile of the network edge parameters.
The function-on-scalar regression model considers the association of the temporal trend
of the network edge parameters with genetic variables, while the linear mixed effects model
only focuses on the association of the network edge parameters with the genetic variables.
The mixed-effects model simply treats the network edge parameters at multiple time points
as repeated measurements and accounts for clustering, which ignores the time order and
trend of the network edge parameters. We view this as a key aspect of the longitudinal data.
Therefore, the function-on-scalar model may be able to find a stronger association between
the network edge parameters with genetics as it accounts explicitly for time ordering (and
not just clustering) in the network response. Thus after preprocessing the data in this way
we are left with 319 scans obtained from 111 subjects for the longitudinal analysis.
MRI for these subjects are collected at 3T. MRI data are downloaded with permission
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from the ADNI. All images were acquired on 3.0 Tesla Philips MRI scanners across 10 North
American acquisitions sites according to the standardized ADNI protocol. Whole-brain
anatomical MRI scans were acquired sagittally, with a T1-weighted MPRAGE sequence,
with the following parameters: 1.2 mm slice thickness, 256 by 256 by 170 acquisition matrix,
echo time (TE) of 3 ms, in-plane voxel dimension of 1 mm2, repetition time (TR) of 7
ms, and flip angle of 9 degrees. Functional MRI scans were obtained during resting-state;
participants were instructed to lay quietly in the scanner with their eyes open. Resting
state fMRI scans were obtained with a T2*-weighted echo-planar imaging sequence with
the following parameters: 140 volumes, 64 by 64 by 48 acquisition matrix (voxel size = 3.3
mm3), TE of 30 ms, TR of 3000 ms, and flip angle of 80 degrees.
The freely available software package PLINK (Purcell et.al., 2007) is used for genomic
quality control and preprocessing. The genetic data are SNPs from non-sex chromosomes,
i.e., chromosome 1 to chromosome 22. SNPs with minor allele frequency less than 5% are
removed as are SNPs with a Hardy-Weinberg equilibrium p-value lower than 10−6 or a
missing rate greater than 5%. After preprocessing we are left with 1,220,955 SNPs for each
of 111 subjects.
2.1 rs-fMRI Data Preprocessing and Network Estimation
The fMRI and anatomical data are pre-processed using a combination of the FSL software
(available at http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/) and the SPM12 software (avail-
able at http://www.l.ion.ucl.ac.uk/spm/software/spm12/). Non-brain tissue in the raw
T1 images is removed using the automated Brain Extraction Tool (Smith, 2002), followed
by manual verification and optimization for each subject. Blood-Oxygen-Level Dependent
(BOLD) image data preprocessing is performed in FSL’s FEAT as follows: each functional
image is motion corrected and registered to their high-resolution T1 structural image that
is linearly registered to standard stereotaxic space using a 12 degree-of-freedom transfor-
mation. A non-linear registration of the structural image to standard stereotactic space is
also applied to account for potential local deformations in brains of the patient group. Each
subject’s imaging data are normalized to a standardized space defined by an MNI template
brain.
Given a set of R brain regions of interest, DCM in the case of fMRI models the haemody-
namic response over these regions through a nonlinear state-space formulation with a model
allowing for interaction between regions and with model parameters that characterize effec-
tive connectivity and, when relevant, how this connectivity is modulated by experimental
inputs. In the case of resting-state fMRI with no experimental inputs, the model can be
expressed as (see, Razi et al., 2017)
x˙(t) = Ax(t) + v(t) (1)
y(t) = h(x(t),θ) + e(t),
where x(t) = (x1(t), . . . , xR(t))
′ are latent variables used to represent the states of neuronal
populations at some time t and x˙(t) is a time-derivative defining a differential equation
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approximating neuronal dynamics, with the R × R matrix A approximating effective con-
nectivity to first-order; h(x(t),θ) is a nonlinear mapping from hidden neuronal states to the
observed haemodynamic response also depending on parameters θ (see, e.g., Friston, 2007,
for details on the form of this nonlinear mapping); y(t) = (y1(t), . . . , yR(t))
′ with yj(t) being
a summary of the response obtained from all voxels within region j; v(t) and e(t) represent
neuronal state noise and measurement noise respectively.
For resting-state fMRI, the DCM can be fit in the time-domain using Bayesian filtering
based on a mean-field variational Bayes approximation (see, e.g., Li et al., 2011) which
involves inference on both model parameters and latent states. Alternatively, the model
can be fit in the spectral domain using an approach known as spectral DCM (Friston et
al., 2014). The latter approach involves relating the theoretical cross spectra associated
with the dynamic model to the sample cross spectra in order to estimate parameters. Thus,
it is somewhat akin to a method of moments approach. More specifically, Friston et al.
(2014) assume a parameterized power law form for the spectral densities of the noise terms
in the state-space model and then express the empirical cross spectra as the sum of the
theoretical cross spectra and measurement error. This formulation then yields a likelihood
for the observed cross spectra statistic depending on the time-invariant parameters but
not depending on the latent variables x(t). This likelihood for the summary statistic is
then combined with a prior distribution for the model parameters and an approximation
to the associated posterior distribution for these parameters is obtained using variational
Bayes. Razi et al. (2015) report simulation results that demonstrate estimators obtained
from spectral DCM having higher accuracy (in the sense of mean-squared error) than those
obtained from stochastic DCM. In addition, the former has a higher computational efficiency
since estimation of the latent states is not required. We use this approach to estimate effective
connectivity networks within the DMN.
The DMN includes the posterior cingulate cortex/precuneus (PCC), medial prefrontal
cortex (MPFC), bilateral inferior parietal lobule (IPL), and other regions including the in-
ferior temporal gyrus. To estimate effective connectivity within the regions of the DMN
depicted in Figure 1 and Table 1, we use spectral DCM as implemented in SPM12 (version
- v71219). BOLD time series from the DMN regions of interest are obtained by extracting
time series from all voxels within an 8mm radius of the associated MNI coordinate, and then
applying a principle component analysis and extracting the first eigenvariate. For simplicity,
the information contained in the other eigenvariates is not considered in our analysis so that
the result is a single representative time series for each region of interest. This procedure is
repeated to obtain a collection of four (DMN4) or eight (DMN8) time series for each subject.
An example of the resulting data for a single subject over DMN4 is depicted in Figure 2.
A 16-parameter (DMN4) or 64-parameter (DMN8) graph with weights representing effec-
tive connectivity between and within regions is then estimated for each subject. This graph
is based on an estimate of the parameter A, an R × R non-symmetric matrix, in equation
(1) obtained from spectral DCM. We fit the DCM in SPM12 with the option of one state per
region and with the model fit to the cross spectral density (which corresponds to spectral
DCM). The imaging preprocessing pipeline is summarized in Figure 3.
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3 Selection of the Disease-Constrained Set of SNPs
Beginning with the 1,220,955 SNPs discussed in Section 2, we conduct a genome-wide as-
sociation study (GWAS) with the goal of identifying a smaller subset of SNPs that are
potentially associated with disease (CN/MCI/AD). This subset serves as a constraint in
subsequent analysis examining effective brain connectivity. A multinomial logistic regres-
sion with disease category as the response is fit for each SNP to assess that SNP’s marginal
association with disease after adjusting for covariates representing age, sex, handedness, and
education. SNPs are included in the model as the number of a particular allele so that a
SNP’s effect on the log-odds ratio is additive. We sort the SNPs by the resulting p-values
from a likelihood ratio test, where the null hypothesis corresponds to the case where the
probability distribution of disease does not depend on the given SNP. A subset of the top
100 SNPs is selected based on this ranking. The distribution of p-values by chromosome and
the cut-off for selecting the best subset of 100 SNPs is depicted in Figure 4. Each of the 100
SNPs in the selected constrained subset has a p-value below 5.657× 10−5, which represents
the cut-off indicated in Figure 4.
While Table 1 indicates an APOE signal in our data from the 4 allele of the gene,
we note that there are no APOE related SNPs in our constrained subset of the top 100.
The highest ranking APOE related SNP is kgp3912453 which has a rank of 1002 out of
1,220,955 SNPs and has a p-value of 0.0005. Thus our choice to use a p-value threshold
of 5.657 × 10−5 in subsequent analyses eliminates the highest ranking APOE related SNP,
even though there appears to be some evidence of an APOE signal in the data. We note
that we have defined APOE related SNPs as those within a 1 million base pair range of
APOE, and there are a total of 503 such SNPs with their p-values ranging between 0.0005
and 0.99. Despite this, all subsequent regression models that we use will include a variable
representing APOEe4 genotype in order to account for its known importance and to adjust
for its potential association with effectivity brain connectivity.
4 Resting-State Effective Brain Connectivity by Ge-
netics
4.1 Longitudinal Analysis with Four DMN Regions
We conduct the longitudinal analysis using both a simple linear mixed effects model incor-
porating subject-specific random effects as well as a function-on-scalar regression. In each
case the response is a network connection between two regions of interest estimated from an
rs-fMRI scan using DCM, and we observe a longitudinal sequence of such connections for
each subject with the number of repeated measurements ranging from 1 to 4 with a median
of 3 and a third-quartile of 4.
For a given connection, we will fit a regression model relating that connection to a single
SNP, for each of the 100 SNPs in the disease-constrained set. These regression models for the
time-sequence of connection values also include covariates representing age, sex, right/left
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hand, education and APOEe4. With 16 possible connections a total of 16 × 100 = 1600
models are fit and in each case a test comparing the model with and without the SNP from
the constrained-set is conducted. The resulting set of 1600 p-values arising from this mass-
univariate approach are adjusted for multiplicity using an FDR adjustment (Benjamini and
Hochberg, 1995).
The linear mixed effect (LME; Kuznetsova et al., 2017) model has the form
Yij = µ+Xiβ +Z
T
i α+ bi + ij
where Yij is the network edge weight estimated from the j
th rs-fMRI scan of the ith subject,
i = 1, 2, ..., 111, j = 1, 2, ...,mi; Xi is the SNP coded additively in the model; Zi contains
the remaining covariates with coefficient vector α, bi is a subject-specific random effect and
ij is an error term with the random effect and errors assumed Gaussian and independent.
The likelihood ratio test is conducted for the hypothesis test H0 : β = 0 against H1 : β 6= 0
and the corresponding p-value obtained.
We apply the PACE approach for sparse functional data to obtain the estimated trajecto-
ries of network edge weights over time t, Ŷi(t). By applying PACE, the estimated trajectory
of each network edge weight can be obtained and expressed as
Ŷi(t) = µ(t) +
J∑
j=1
ξijφj(t),
Ŷ (t) = µ(t) + ξn×JΦ(t)J×1,
where µ(t) represents the mean function common to all n subjects,
ξij =
∫
{Yi(t)− µ(t)}φj(t)dt
is the j-th functional principal component (FPC) score for Yi(t), with φj(t) being the corre-
sponding eigenfunction, and J = 3 since three functional principal components explain over
95% of the total of variation.
The function-on-scalar regression model has the form
Yi(t) = Xiα(t) +Z
T
i β(t) + i(t),
where Xi is the SNP with corresponding regression function α(t), Zi is a vector holding
covariates representing age, sex, right/left hand, education and APOEe4 with corresponding
regression function β(t) and the error term i(t) is a random error processes. As the raw data
Yi(t) is sparse we replace it in the regression model with the PACE-estimated trajectory of
each network edge weight. We test H0 : α(t) = 0 corresponding to the model that excludes
the genetic marker using an F -test. As with our use of linear mixed models we apply a mass
univariate approach and apply the model to all 16 × 100 = 1600 possible combinations of
network edge and SNP, and apply an FDR correction for multiplicity.
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The results arising from applying the linear mixed model approach and the function-on-
scalar regression approach are presented in Tables 3 and 4, respectively, which show results
corresponding to FDR adjusted p-values less than 0.1. Both LME and FSR identify the
same potential association between the connection from the posterior cingulate cortex to
the left intraparietal cortex and a genetic signal represented by SNP rs2602615/kgp3833472
on chromosome 2 (FDR adjusted p-value = 0.092 for FSR; FDR adjusted p-value = 0.096
for LME). Both LME and FSR identify the same potential association suggesting a strong
degree of robustness to model assumptions.
4.2 Longitudinal Analysis with Eight DMN Regions
We apply the same approaches to the networks estimated using spectral DCM for the network
of 8 regions listed in Table 1. In this case the models are applied to 64×100 = 6400 possible
combinations of network edge and SNP, and an FDR correction is applied to adjust the p-
value for multiplicity. For DMN8, LME does not identify any edge-SNP combinations with
FDR adjusted p-value ≤ 0.1. In contrast, FSR may be more powerful as it incorporates the
information on time-ordering (on the time scale of fMRI scans) and the corresponding results
are presented in Table 5. Examining Table 5, the difference in the results we see in moving
from DMN4 to DMN8 can be explained by the heavy involvement of the right hippocampus
(RH) and right inferior temporal (RIT) region which are nodes in DMN8 but not in DMN4.
These regions are involved in seven of the ten results reported in Table 5.
FSR suggests potential associations between the connections from the left intraparietal
cortex to the right inferior temporal cortex and SNP kgp7160266 from chromosome 12 (FDR
adjusted p-value = 0.038); the connection from the left intraparietal cortex to the right
intraparietal cortex and SNP rs7190071 from chromosome 16 (FDR adjusted p-value =
0.040), the connection from the right hippocampus to the posterior cingulate cortex and SNP
kgp10652659 from chromosome 11 (FDR adjusted p-value = 0.050) and the connection from
the right hippocampus to right intraparietal cortex and SNP rs7617199 from chromosome 3
(FDR adjusted p-value = 0.050).
5 Discussion
We have examined the association between longitudinal effective brain connectivity and
genetics based on an empirically derived disease-constrained set of SNPs using LME and
FSR, with networks estimated from rs-fMRI time series using spectral DCM. Our analysis
is based on conditioning on the outcome of the GWAS in Section 3, the purpose being to
focus attention on potential associations that are empirically most relevant for disease. We
have examined both a 4-region and an 8-region network depicted in Figure 1 and Table 1
and our primary results are summarized as follows:
1. DMN4: both FSR and LME identify a potential association between the connection
from the posterior cingulate cortex to the left intraparietal cortex and a genetic signal
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represented by SNP rs2602615/kgp3833472 on chromosome 2 (FDR adjusted p-value
= 0.092 for FSR; FDR adjusted p-value = 0.096 for LME).
2. DMN8: FSR suggests a potential association between the connections from the left
intraparietal cortex to the right inferior temporal cortex and SNP kgp7160266 from
chromosome 12 (FDR adjusted p-value = 0.038).
3. DMN8: FSR suggests a potential association between the connection from the left
intraparietal cortex to the right intraparietal cortex and SNP rs7190071 from chromo-
some 16 (FDR adjusted p-value = 0.040).
4. DMN8: FSR suggests a potential association between the connection from the right
hippocampus to the posterior cingulate cortex and SNP kgp10652659 from chromosome
11 (FDR adjusted p-value = 0.050).
5. DMN8: FSR suggests a potential association between the connection from the right
hippocampus to right intraparietal cortex and SNP rs7617199 from chromosome 3
(FDR adjusted p-value = 0.050).
Our current analysis suggests follow-up analyses looking at high resolution anatomical
and diffusion tensor imaging and structural connectivity in a separate sample of subjects with
such an analysis focussed on a small number of targeted SNPs suggested by the current analy-
sis. From a methodological perspective, our approach of determining the disease-constrained
set first and subsequently examining relationships with effective brain connectivity motivate
the development of a joint model examining both disease and longitudinal effective connec-
tivity simultaneously with a model structure that allows for joint variable (SNP) selection.
The neuropathological mechanisms that underly the effective connectivity observed in
this study could be related to the usual hallmarks of AD and MCI. For example, amyloid
plaques, neurofibrillary tangles and/or structural neurodegeneration may underly effective
connectivity as well. Therefore, our current results suggest follow-up studies incorporating
measures of amyloid beta and tau (as measured in CSF or by PET imaging) and measures of
brain structure (as measured by high resolution anatomical and diffusion tensor imaging) and
examination of the relationship between these measures and the genetic variables suggested
by this analysis.
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Figure 1: The locations of the four regions within the default mode network (DMN) examined
in our DMN4 study: the medial prefrontal cortex (MPFC), the posterior cingulate cortex
(PCC), the left and right intraparietal cortex (LIPC and RIPC) with MNI coordinates MPFC
(3, 54, -2), the PCC (0, -52, 26), LIPC (-50, -63, 32) and RIPC (48, -69, 35).
18
Figures
Figure 2: An example of the rs-fMRI data used to estimate the effective connectivity network
for a single subject from the four regions of interest (PCC, MPFC, LIPC, RIPC).
19
Figure 3: The neuroimaging data preprocessing pipeline used in our study.
20
Figure 4: The p-values associating disease status with SNPs adjusting for age, sex, handed-
ness, and education. The blue line represents the cutoff used to obtain the top 100 SNPs
which corresponds to a p-value threshold of 5.657× 10−5.
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Tables
DMN Region MNI Coordinate
1 Posterior cingulate (PCC) 0, -52, 26
2 Medial Prefrontal (MPFC) 3, 54, -2
3 Left intraparietal cortex (LIPC) -50, -63, 32
4 Right intraparietal cortex (RIPC) 48, -69, 35
5 Left inferior temporal (LIT) -61, -24, -9
6 Right inferior temporal (RIT) 58, -24, -9
7 Left Hippocampus (LH) -29, -19, -15
8 Right Hippocampus (RH) 25, -16, -20
Table 1: The MNI coordinates associated with the regions of interest in our study. The first
four rows correspond to the network DMN4 while DMN8 corresponds to all eight rows.
22
Table 2: Distribution of demographic variables across disease groups within our sample of
111 subjects. The p-values in the final column are based on a one-way ANOVA for continuous
variables and a Fisher’s exact test for categorical variables.
AD MCI CN p-value
n 12 63 36
GENDER (% of group) Female 8 (66.7) 34 (54.0) 23 (63.9) 0.6402
Male 4 (33.3) 29 (46.0) 13 (36.1)
HAND (% of group) Left 1 ( 8.3) 2 ( 3.2) 2 ( 5.6) 0.5036
Right 11 (91.7) 61 (96.8) 34 (94.4)
Age - mean (sd) 75.82 (7.91) 72.70 (7.66) 75.35 (6.73) 0.15
EDUCATION - mean (sd) 16.33 (2.53) 16.06 (2.66) 16.19 (2.14) 0.929
APOE 4 Alleles (% of group) Zero 1 ( 8.3) 35 (55.6) 24 (66.6) 0.0045
One 9 (75.0) 22 (34.9) 11 (30.6)
Two 2 (16.7) 6 ( 9.5) 1 ( 2.8)
23
Network Edge SNP Adjusted p-value Chromosome
1 PCC→LIPC rs2602615 C 0.096 2
2 PCC→LIPC kgp3833472 A 0.096 2
Table 3: The table reports the results of the linear mixed effects model longitudinal analysis
of pairs of network edges with SNPs that are relatively highly ranked based on the corrected
FDR adjusted p-values after adjusting for 1600 tests performed using the DMN4 data.
Network Edge SNP Adjusted p-value Chromosome
1 PCC→LIPC rs2602615 C 0.092 2
2 PCC→ LIPC kgp3833472 A 0.092 2
Table 4: The table reports the results of the function-on-scalar regression longitudinal anal-
ysis of pairs of network edges with SNPs that are relatively highly ranked based on the
corrected FDR adjusted p-values after adjusting for 1600 tests performed using the DMN4
data.
24
Network Edge SNP Adjusted p-value Chromosome
1 LIPC→RIT kgp7160266 A 0.038 12
2 LIPC→RIPC rs7190071 T 0.040 16
3 RH →PCC kgp10652659 A 0.050 11
4 RH→RIPC rs7617199 A 0.050 3
5 LIPC→LIPC rs7190071 T 0.063 16
6 LIPC →PCC rs442277 A 0.070 22
7 RIT→RH rs10228800 G 0.077 7
8 MPFC→RH kgp10932192 C 0.089 3
9 RIT→PCC rs3101340 A 0.091 1
10 RIT→PCC rs1870676 T 0.091 1
Table 5: The table reports the results of the function-on-scalar regression longitudinal anal-
ysis of pairs of network edges with SNPs that are relatively highly ranked based on the
corrected FDR adjusted p-values after adjusting for 6400 tests performed using the DMN8
data.
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